- Home
- IVP vs AIMD Comparison
IVP vs AIMD Comparison
Compare IVP & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- AIMD
- Stock Information
- Founded
- IVP 2020
- AIMD 1984
- Country
- IVP United States
- AIMD United States
- Employees
- IVP N/A
- AIMD N/A
- Industry
- IVP Diversified Commercial Services
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- IVP Miscellaneous
- AIMD Health Care
- Exchange
- IVP Nasdaq
- AIMD Nasdaq
- Market Cap
- IVP 7.3M
- AIMD 6.0M
- IPO Year
- IVP 2023
- AIMD N/A
- Fundamental
- Price
- IVP $0.19
- AIMD $0.46
- Analyst Decision
- IVP
- AIMD
- Analyst Count
- IVP 0
- AIMD 0
- Target Price
- IVP N/A
- AIMD N/A
- AVG Volume (30 Days)
- IVP 1.5M
- AIMD 132.1K
- Earning Date
- IVP 11-13-2024
- AIMD 11-06-2024
- Dividend Yield
- IVP N/A
- AIMD N/A
- EPS Growth
- IVP N/A
- AIMD N/A
- EPS
- IVP N/A
- AIMD N/A
- Revenue
- IVP $17,054,777.00
- AIMD $40,633.00
- Revenue This Year
- IVP N/A
- AIMD N/A
- Revenue Next Year
- IVP N/A
- AIMD N/A
- P/E Ratio
- IVP N/A
- AIMD N/A
- Revenue Growth
- IVP 6.12
- AIMD N/A
- 52 Week Low
- IVP $0.18
- AIMD $0.40
- 52 Week High
- IVP $50.00
- AIMD $4.29
- Technical
- Relative Strength Index (RSI)
- IVP 36.55
- AIMD 49.75
- Support Level
- IVP $0.20
- AIMD $0.42
- Resistance Level
- IVP $0.22
- AIMD $0.48
- Average True Range (ATR)
- IVP 0.02
- AIMD 0.04
- MACD
- IVP 0.01
- AIMD 0.00
- Stochastic Oscillator
- IVP 17.81
- AIMD 36.48
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.